pnb-0408 dihexa clinical trial (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Dihexa (PNB-0408) | Angiotensin IV

Description

Report new vision changes, severe weakness, or swelling promptly

Product Attributes CAS # : 62568-57-4 Molecular Formula : C35H48N10O15 Sequence (AA) : WAGGDASGE Molecular Weight : 848.8 g/mol PubChem CID : 68816 Half-Life : ~7-15 minutes Synonyms : Delta Sleep-Inducing Peptide, DSIP-9, Delta-Sleep Inducing Nonapeptide Type : Endogenous research neuropeptide (nonapeptide) Research Focus : Sleep & Recovery, Stress & Neuroendocrine Modulation Scientific References Delta sleep-inducing peptide (DSIP): a review Observational | Animal | In vitro Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients Human RCT | Observational The delta sleep-inducing peptide (DSIP): a still unresolved riddle Animal | In vitro DSIP in the treatment of chronic insomnia: a double-blind clinical trial Human RCT Influence of DSIP on the secretion of pituitary hormones in humans Observational | Human RCT Delta sleep-inducing peptide modulates the stress response in rats Animal Delta sleep-inducing peptide: structure, function and clinical perspectives Observational | Animal | In vitro Antioxidant properties of delta sleep-inducing peptide in experimental models Animal | In vitro Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator

Cells are separated from the interstitial fluid by a selectively permeable cell membrane that helps regulate the passage of materials between the interstitial fluid and the interior of the cell